The Journal of Urology
Volume 178, Issue 6 , Page 2377, December 2007

Editorial Comment

Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts

published online 15 October 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0022-5347(07)02314-2

doi:10.1016/j.juro.2007.08.114

Refers to article:

  • Phase II Study of Ketoconazole Plus Granulocyte-Macrophage Colony-Stimulating Factor for Prostate Cancer: Effect of Extent of Disease on Outcome , 15 October 2007

    Charles J. Ryan, Vivian Weinberg, Jonathan Rosenberg, Lawrence Fong, Amy Lin, Jennifer Kim, Eric J. Small
    The Journal of Urology December 2007 (Vol. 178, Issue 6, Pages 2372-2377)

The Journal of Urology
Volume 178, Issue 6 , Page 2377, December 2007

Article Tools